Strain Information | |
---|---|
Image | |
BRC No. | RBRC10427 |
Type | CRISPR/Cas9 (Transgene)![]() |
Species | Mus musculus |
Strain name | C57BL/6N-Slco1a1<em1Sato> |
Former Common name | Slco1a1 floxed |
H-2 Haplotype | |
ES Cell line | RENKA [C57BL/6NCrlCrlj] |
Background strain | C57BL/6NCrSlc |
Appearance | |
Strain development | Developed by Thomas N. Sato, Advanced Telecommunications Research Institute International, in 2017. This strain was generated by the CRISPR/Cas9 using RENKA ES cells derived from C57BL/6N. C57BL/6N genetic background. |
Strain description | Slco1a1 (solute carrier organic anion transporter family, member 1a1) floxed mice. A pair of loxP flanks Exon 2 of the Slco1a1 gene. |
Colony maintenance | |
References |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Slco1a1 MGI:1351891 | solute carrier organic anion transporter family, member 1a1 | 6 | Slco1a1<em1Sato> | endonuclease mediated mutation 1, Thomas N. Sato |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | pX330-U6-Chimeric_BB-CBh-hSpCas9[human U6 promoter, S. pyogenes gRNA scaffold, human U6 terminator, CMV,chicken hybrid CMV enhancer/chicken beta-actin promoter (CBh), Synthetic DNA 3xFLAG, SV40 nuclear localization signal(NLS), Streptococcus pyogenes SpCas9 (human codon-optimized), bovine GH polyA signal, AAV2 inverted terminal repeat (ITR), f1 phage f1 origin, E. coli Ampicillin resistance gene (AmpR), E. coli pUC origin], bacteria P1 phage loxP, |
Research application | Cre/loxP system |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Thomas N. Sato (Advanced Telecommunications Research Institute International (ATR)) |
Strain Status | ![]() |
Strain Availability | ![]() |
Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
---|
No Data |